Patients with Medicaid or no insurance may have worse survival outcomes compared with Medicare or private insurance in those with metastatic renal cell carcinoma. Patients with metastatic renal cell ...

The approval of immune checkpoint inhibitors (ICIs) was associated with a significant improvement in 2-year overall survival among patients with advanced-stage melanoma, non-small cell lung cancer ...

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. As a cancer patient, access to innovative drugs can help extend your life — that is if you have ...

NEW YORK (Reuters Health) - People with cancers of the head or neck seem to have better survival odds if they have private health insurance, research hints. Head and neck cancers include cancers of ...

Population based testing and treatment characteristics for CML. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.

Lung cancer is the nation's No. 1 cancer killerBut survival rates are improving, a nationwide review showsThe authors credit biomarker testing and call on states to require insurers to cover it ...

Survival for patients with colorectal cancer is influenced by insurance status. Age adjusted 1-, 2-, and 3-year relative survival for patients with AML by insurance type.